Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
Charpentier
B
B
Service de Néphrologie, University Hospital of Bicêtre, Bicêtre, France.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D065095:Calcineurin Inhibitors; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology*; D012449:Safety; D016559:Tacrolimus / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D003404:Creatinine; D016559:Tacrolimus